Completed PHASE1 INTERVENTIONAL 1-arm NCT02190708

Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole

A Phase I, Open Label Study to Assess the Effects of PQ912 on the Pharmacokinetics of Midazolam and Omeprazole in Healthy Male Subjects

Sponsor: Covance

Conditions Healthy Volunteers Pharmacologic Action

Interventions Midazolam Omeprazole PQ912

Updated 7 times since 2017 Last updated: Oct 19, 2015 Started: Jun 30, 2014 Primary completion: Jun 30, 2014 Completion: Aug 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE1 trial investigates Healthy Volunteers and Pharmacologic Action and is currently completed. Covance leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Oct 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Oct 2021 [monthly]

Completed PHASE1
Dec 2019 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 2 earlier versions

Jun 2018 — Dec 2019 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Covance
Vivoryon Therapeutics N.V.

Data source: Vivoryon Therapeutics N.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Leeds, United Kingdom